Fatigue News and Research

RSS

Synbiotic formula shows promise in reducing long COVID symptoms

Study finds that the synbiotic preparation SIM01 significantly reduces post-acute COVID-19 syndrome symptoms in patients, including fatigue, memory issues, and gastrointestinal distress, indicating its potential as a treatment for long COVID.

11 Dec 2023

New drug combo shows promise in targeting RAS-mutant multiple myeloma

The combination of a drug and a protein fragment prevents the growth of blood cancer cells, a new study in mice shows.

11 Dec 2023

Advanced MRI offers insights into the underlying mechanisms of neurological problems after COVID-19

Researchers at Linköping University have examined the brains of 16 patients previously hospitalized for COVID-19 with persisting symptoms.

11 Dec 2023

Study shows community-based mental health services reduce stigma and inequalities

How co-location in community settings, such as libraries, faith institutions, and community centers, affects mental health outcomes.

11 Dec 2023

Phase 2 trial data shows safety, tolerability and efficacy of imlifidase in GBS patients

Hansa Biopharma today announced positive high-level data from the 15-HMedIdeS-09 phase 2 trial that demonstrated imlifidase was safe and well tolerated when administered prior to standard of care, including rapid improvement in disease-related efficacy measures.

11 Dec 2023

Varied early symptoms of bacterial meningitis in adults and children highlight diagnostic challenges

This study in Scientific Reports reveals that symptoms of community-acquired bacterial meningitis (CABM) vary between children and adults, emphasizing the need for tailored approaches in early diagnosis and treatment to improve outcomes.

10 Dec 2023

New guidelines offer hope for fatigue management in people with inflammatory RMD

Fatigue is common in people with inflammatory rheumatic and musculoskeletal diseases(RMD). The causes of fatigue are not well understood, and it is likely that they vary between people and over time.

8 Dec 2023

Exercise may become part of standard treatment for metastatic breast cancer, study suggests

Among patients with metastatic breast cancer, those who took part in a nine-month structured exercise program reported less fatigue and an improved quality of life compared to those who did not undergo the exercise program, according to results from the PREFERABLE-EFFECT trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.

7 Dec 2023

Long COVID patients exhibit significant cognitive slowing, new study finds

Researchers find that patients with long COVID exhibit moderate-to-severe cognitive slowing compared to controls, highlighting a distinct cognitive signature of post-COVID-19 condition.

6 Dec 2023

Thalamus-targeted deep brain stimulation improves cognition in brain injury patients

Study shows that deep brain stimulation (DBS) of the central lateral thalamic nuclei and medial dorsal tegmental tract improves executive function in patients with moderate-severe traumatic brain injury, offering a potential new treatment approach.

6 Dec 2023

Neoadjuvant chemotherapy can eliminate need for regional nodal irradiation in breast cancer

For patients whose breast cancer converted from lymph node-positive to lymph node-negative disease after neoadjuvant chemotherapy, skipping adjuvant regional nodal irradiation (RNI) did not increase the risk of disease recurrence or death five years after surgery, according to results from the NRG Oncology/NSABP B-51/RTOG 1304 clinical trial presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.

6 Dec 2023

Music could hold the key to developing effective mental health interventions

How human beings respond to music and the biological underpinnings of this response.

6 Dec 2023

Evaluating the safety and efficacy of thalamic DBS in treating traumatic brain injury

The safety and efficacy of deep brain stimulation.

4 Dec 2023

Study finds long-COVID symptoms fluctuate over time, challenging treatment approaches

Study reveals that over half of long Covid patients experience fluctuating symptom severities over time, highlighting the dynamic nature of the condition. The research underscores the need for adaptive healthcare interventions and self-management strategies, considering these symptom variations in long Covid cases.

30 Nov 2023

New guideline emphasizes prevention, early rhythm control for atrial fibrillation

The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally managing atrial fibrillation (AFib).

30 Nov 2023

Lyme disease aftercare: new insights into persistent symptoms

Study explores the causes of persistent symptoms after Lyme borreliosis (LB) treatment, revealing that factors like social and physical functioning, psychological distress, and comorbidities are key determinants.

29 Nov 2023

From 'Covidiots' to 'zoom fatigue': The new words of the pandemic

Remember 'Covidiots' and the first protests by 'anti-vaxxers'? The early stages of the pandemic saw plenty of new words enter the public 'voice', but many of these novel terms were actually fairly short-lived.

27 Nov 2023

Half-dose Pfizer COVID booster nearly as effective as full dose with fewer side effects

Study compares the half-dose and full-dose Pfizer-BioNTech BNT162b2 COVID-19 booster in adults previously vaccinated with ChAdOx1, BBIBP-CorV, or Gam-COVID-Vac. It finds that the half-dose booster has fewer side effects and maintains similar immunogenicity, offering a viable option for booster vaccination strategies.

27 Nov 2023

Many autoimmune disease patients struggle with diagnosis, costs, inattentive care

After years of debilitating bouts of fatigue, Beth VanOrden finally thought she had an answer to her problems in 2016 when she was diagnosed with Hashimoto's disease, an autoimmune disorder.

27 Nov 2023

COVID-19 vaccines offer protection against long-term effects, study suggests

A new study in The BMJ explores how far vaccination averted PCC.

24 Nov 2023

Fatigue News and Research

Synbiotic formula shows promise in reducing long COVID symptoms

New drug combo shows promise in targeting RAS-mutant multiple myeloma

Advanced MRI offers insights into the underlying mechanisms of neurological problems after COVID-19

Study shows community-based mental health services reduce stigma and inequalities

Phase 2 trial data shows safety, tolerability and efficacy of imlifidase in GBS patients

Varied early symptoms of bacterial meningitis in adults and children highlight diagnostic challenges

New guidelines offer hope for fatigue management in people with inflammatory RMD

Exercise may become part of standard treatment for metastatic breast cancer, study suggests

Long COVID patients exhibit significant cognitive slowing, new study finds

Thalamus-targeted deep brain stimulation improves cognition in brain injury patients

Neoadjuvant chemotherapy can eliminate need for regional nodal irradiation in breast cancer

Music could hold the key to developing effective mental health interventions

Evaluating the safety and efficacy of thalamic DBS in treating traumatic brain injury

Study finds long-COVID symptoms fluctuate over time, challenging treatment approaches

New guideline emphasizes prevention, early rhythm control for atrial fibrillation

Lyme disease aftercare: new insights into persistent symptoms

From 'Covidiots' to 'zoom fatigue': The new words of the pandemic

Half-dose Pfizer COVID booster nearly as effective as full dose with fewer side effects

Many autoimmune disease patients struggle with diagnosis, costs, inattentive care

COVID-19 vaccines offer protection against long-term effects, study suggests

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News